This webinar series is organised on the occasion of the finalisation of the EU-funded project FREIA. It specifically addresses the scientific findings of the partners after five years of research on the effects of endocrine disrupting chemicals (EDCs) on female reproduction.
Click on a title below to view the recording.
Some recordings will be made available after publication of the results
Agne Velthut-Meikas, Tallinn University of Technology, Estonia.
‘EDCs in the human ovarian follicle: how do they affect ovarian function?‘
Ana Soto, TUFTS University School of Medicine, USA.
‘The rat mammary gland is a sensitive read-out for EDC exposure’
Anne-Simone Parent, University of Liege, Belgium.
‘EDCs and the onset of puberty‘
Eva Bay Wedebye, Danish Technical University, Denmark.
‘Development of QSAR models in the FREIA project to predict mechanistic key events related to female fertility’
Hanna KL Johansson, Danish Technical University, Denmark.
‘Sensitive windows during development and potential biomarkers for female reproductive toxicity‘
Ida Hallberg, Uppsala University, Sweden.
‘Linking lifestyle factors to fertility treatment outcomes: IVF cohort studies‘
Indusha Kughatas, University of Rennes, France.
‘Investigating the impact of endocrine disruptors on ovaries through transcriptomic signatures: from data acquisition to collaborative sharing‘
Majorie van Duursen, Vrije Universiteit Amsterdam, The Netherlands.
‘Extensive steroidomic profiling to identify EDCs’
Pauliina Damdimopoulou, Karolinska Institute, Sweden.
‘The adult human ovary’
Séverine Mazaud-Guittot, University of Rennes, France.
‘How EDCs can interfere with the construction of the foetal ovary: the case of humans’
Yuling Xie, Queen’s University of Belfast, Ireland.
‘Human ovarian toxicity models in vitro: the human estrogen receptor beta‘
Last update: 7 June 2024, 10:56